{"id":631605,"date":"2018-03-22T04:13:49","date_gmt":"2018-03-22T04:13:49","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/"},"modified":"2018-03-22T04:13:49","modified_gmt":"2018-03-22T04:13:49","slug":"ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/","title":{"rendered":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years"},"content":{"rendered":"

INVESTMENT WATCH- Ibnsina Pharma is looking to invest EGP 150-200 mn over the next five years to increase its market share to 26% <\/strong>from a current 19.3%, Managing Director Omar Abdel Gawad tells Al Mal<\/a>. The new funds would bring the company\u2019s total investments to EGP 700 mn, a target it had announced at the time of its initial public offering last year.<\/a> Ibnsina plans to grow its distribution network, adding new government contracts (which earned the company EGP 1 bn in 2017), and growing its portfolio through ongoing talks with international med manufacturers, Abdel Gawad adds. The news comes one day after<\/a> Ibnsina announced signing contract with Novo Nordisk<\/strong> to distribute over 20 SKUs of its diabetes care, haemophilia and growth disorders products in Egypt.<\/p>\n","protected":false},"excerpt":{"rendered":"

INVESTMENT WATCH- Ibnsina Pharma is looking to invest EGP 150-200 mn over the next five years to increase its market share to 26% from a current 19.3%, Managing Director Omar Abdel Gawad tells Al Mal. The new funds would bring the company\u2019s total investments to EGP 700 mn, a target it had announced at the […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-631605","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"4c92b51f-a640-44b6-b7cc-2b34e8adc222","order":"0","is_powered_by":true,"section_story_id":"7bab2275-54a4-40b5-a333-a41e3b3bfcda","story_type":"1","photo_url":"","photo_position":"above","related_issue":[631591],"teaser":"","voice_url":""},"yoast_head":"\nIbnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years\" \/>\n<meta property=\"og:description\" content=\"INVESTMENT WATCH- Ibnsina Pharma is looking to invest EGP 150-200 mn over the next five years to increase its market share to 26% from a current 19.3%, Managing Director Omar Abdel Gawad tells Al Mal. The new funds would bring the company\u2019s total investments to EGP 700 mn, a target it had announced at the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-22T04:13:49+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years\",\"datePublished\":\"2018-03-22T04:13:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/\"},\"wordCount\":134,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/\",\"name\":\"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2018-03-22T04:13:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/","og_locale":"en_US","og_type":"article","og_title":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years","og_description":"INVESTMENT WATCH- Ibnsina Pharma is looking to invest EGP 150-200 mn over the next five years to increase its market share to 26% from a current 19.3%, Managing Director Omar Abdel Gawad tells Al Mal. The new funds would bring the company\u2019s total investments to EGP 700 mn, a target it had announced at the […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2018-03-22T04:13:49+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years","datePublished":"2018-03-22T04:13:49+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/"},"wordCount":134,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/","url":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/","name":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2018-03-22T04:13:49+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":595825,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/08\/07\/earnings-watch-ibnsina-pharma\/","url_meta":{"origin":631605,"position":0},"title":"Earnings watch: Ibnsina Pharma","author":"enterpriseam admin","date":"7 August 2019","format":false,"excerpt":"EARNINGS WATCH- Ibnsina Pharma\u2019s 2Q2019 profits surge 26% y-o-y: Ibnsina Pharma reported a 26% y-o-y increase in consolidated net profits to EGP 60.5 mn in 2Q2019, up from EGP 48 mn last year, the company said in a statement (pdf). Revenues rose 24% y-o-y to EGP 3.9 bn. The company\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":594775,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/09\/08\/shareholders-sell-8-4-stake-in-egypts-ibnsina-pharma\/","url_meta":{"origin":631605,"position":1},"title":"Shareholders sell 8.4% stake in Egypt\u2019s Ibnsina Pharma","author":"enterpriseam admin","date":"8 September 2019","format":false,"excerpt":"Shareholders sell 8.4% stake in Ibnsina: Shareholders have sold 8.4% of their shares in Ibnsina Pharma, amounting to around 69.1 mn shares, at EGP 9.7-10.22 per share, according to an emailed statement from EFG Hermes (pdf). Among the sellers was the European Bank for Reconstruction and Development (EBRD), which reduced\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/4\/308.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":564174,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/08\/15\/ibnsina-net-income-up-45-in-2q2021\/","url_meta":{"origin":631605,"position":2},"title":"Ibnsina net income up 45% in 2Q2021","author":"enterpriseam admin","date":"15 August 2021","format":false,"excerpt":"EARNINGS WATCH- Ibnsina Pharma saw its net income rise more than 45% to EGP 56.3 mn in 2Q2021, compared to EGP 38.7 mn in the same period last year, according to the company\u2019s earnings release (pdf). The bottom-line growth was fuelled by a 21% rise in revenues, which reached almost\u2026","rel":"","context":"In "GO WITH THE FLOW"","block_context":{"text":"GO WITH THE FLOW","link":"https:\/\/enterpriseam.com\/egypt\/category\/go-with-the-flow\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":635517,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/12\/06\/ibnsina-to-allocate-egp-250-mn-from-ipo-to-capital-increase-plans-to-invest-egp-700-mn-in-five-years\/","url_meta":{"origin":631605,"position":3},"title":"Ibnsina to allocate EGP 250 mn from IPO to capital increase, plans to invest EGP 700 mn in five years","author":"enterpriseam admin","date":"6 December 2017","format":false,"excerpt":"IPO WATCH- Ibnsina Pharma will allocate EGP 280 mn of the proceeds from its EGP 1.56 bn IPO towards a capital increase in 1Q2018 and to cover exits by current shareholders, CEO Mahmoud Abdel Gawad told Reuters in an interview on Tuesday. Ibnsina is planning to invest EGP 700 mn\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":566148,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/05\/31\/sodic-ibnsina-report-higher-net-incomes-oih-narrows-net-losses\/","url_meta":{"origin":631605,"position":4},"title":"Sodic, Ibnsina report higher net incomes, OIH narrows net losses","author":"enterpriseam admin","date":"31 May 2021","format":false,"excerpt":"EARNINGS WATCH- Sodic\u2019s bottom line surged over three-fold in 1Q2021, reaching EGP 100 mn after tax and minority interest, from only EGP 30 mn in the same quarter last year, the upmarket developer said in its earnings release (pdf). Revenues for the quarter increased 60% y-o-y to EGP 849 bn,\u2026","rel":"","context":"In "GO WITH THE FLOW"","block_context":{"text":"GO WITH THE FLOW","link":"https:\/\/enterpriseam.com\/egypt\/category\/go-with-the-flow\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":573721,"url":"https:\/\/enterpriseam.com\/egypt\/2020\/08\/16\/prime-holding-reports-egp-18-mn-loss-arabian-cement-reports-egp-5-64-loss-for-1h2020-ibnsina-pharma-reports-16-growth-in-revenues\/","url_meta":{"origin":631605,"position":5},"title":"Prime Holding reports EGP 18 mn loss, Arabian Cement reports EGP 5.64 loss for 1H2020, Ibnsina Pharma reports 16% growth in revenues","author":"enterpriseam admin","date":"16 August 2020","format":false,"excerpt":"EARNINGS WATCH- Ibnsina Pharma\u2019s net profits dipped 36.8% y-o-y to EGP 38.7 mn in 2Q2020, from EGP 62.2 mn in 2Q2019, according to the company\u2019s earnings release (pdf). Ibnsina reported EGP 4.4 bn in revenues during the quarter, up 16% y-o-y from EGP 3.82 bn. In the first half of\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/631605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=631605"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/631605\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/631591"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=631605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=631605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=631605"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=631605"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=631605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}